valsartan has been researched along with Fasting Hypoglycemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Claggett, B; Cunningham, JW; Jackson, A; Lefkowitz, M; McMurray, JJV; Packer, M; Pfeffer, MA; Rouleau, J; Rørth, R; Shah, SJ; Solomon, SD; Swedberg, K; Vaduganathan, M; Wijkman, MO; Zile, M | 1 |
| Wang, L; Wang, R; Wang, Y; Wei, J; Ye, H; Zhang, X; Zhao, Y | 1 |
| Mastaitis, JW; Mobbs, CV; Poplawski, MM | 1 |
1 review(s) available for valsartan and Fasting Hypoglycemia
| Article | Year |
|---|---|
Effect of sacubitril/valsartan and ACEI/ARB on glycaemia and the development of diabetes: a systematic review and meta-analysis of randomised controlled trials.
Topics: Aminobutyrates; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Diabetes Mellitus; Drug Combinations; Heart Failure; Humans; Hypoglycemia; Randomized Controlled Trials as Topic; Stroke Volume; Tetrazoles; Valsartan | 2022 |
2 other study(ies) available for valsartan and Fasting Hypoglycemia
| Article | Year |
|---|---|
Effects of sacubitril/valsartan on glycemia in patients with diabetes and heart failure: the PARAGON-HF and PARADIGM-HF trials.
Topics: Aminobutyrates; Angiotensin Receptor Antagonists; Biphenyl Compounds; Blood Glucose; Diabetes Mellitus; Enalapril; Glycated Hemoglobin; Heart Failure; Humans; Hypoglycemia; Insulins; Stroke Volume; Tetrazoles; Valsartan; Ventricular Function, Left | 2022 |
Naloxone, but not valsartan, preserves responses to hypoglycemia after antecedent hypoglycemia: role of metabolic reprogramming in counterregulatory failure.
Topics: Angiopoietin-Like Protein 4; Angiopoietins; Animals; Antihypertensive Agents; Apoptosis Regulatory Proteins; Blood Glucose; Carrier Proteins; Cyclin-Dependent Kinase Inhibitor p21; Glucose Transporter Type 2; Glycerolphosphate Dehydrogenase; Homeostasis; Hypoglycemia; Insulin; Membrane Proteins; Mice; Naloxone; Narcotic Antagonists; Perilipin-4; Protein Serine-Threonine Kinases; Pure Autonomic Failure; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; Tetrazoles; Transcription Factors; Valine; Valsartan | 2011 |